Page last updated: 2024-11-04

terfenadine and Liver Cirrhosis, Biliary

terfenadine has been researched along with Liver Cirrhosis, Biliary in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Liver Cirrhosis, Biliary: FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duncan, JS1
Kennedy, HJ1
Triger, DR1

Trials

1 trial available for terfenadine and Liver Cirrhosis, Biliary

ArticleYear
Treatment of pruritus due to chronic obstructive liver disease.
    British medical journal (Clinical research ed.), 1984, Jul-07, Volume: 289, Issue:6436

    Topics: Benzhydryl Compounds; Chlorpheniramine; Cholangitis; Cholestyramine Resin; Clinical Trials as Topic;

1984